NJR welcomes new Epidemiologist
and Public Health member
26 February 2014
The National Joint Registry is delighted to welcome Professor Mark Wilkinson to the NJR Steering Committee
as the Epidemiologist and Public Health member this month.
“With more than 270 data requests received last year, and the growing interest in NJR data for research, we are pleased to welcome Professor Wilkinson on board. He brings a wealth of experience in study design of large and complicated datasets as well as a track record of published research of national recognition” NJR Chairman Laurel Powers-Freeling announced. “Mark will help the registry to grow its ambitious plans for a renewed, wide-reaching and collaborative research strategy – the aim of which is to drive improvement in joint replacement surgery” Powers-Freeling concluded.
The post, effective from 1 February 2014, sees Professor Wilkinson take up Chairmanship of the Research Sub-committee
as well as membership of the NJR Editorial Board.
NJR National Lead Elaine Young added: “At ten years of data, this is an exciting time for the registry and facilitating research is a key strategic ambition. I look forward to working with Mark to achieve these goals. I would also like to express sincere thanks to outgoing member Professor Alex MacGregor who has been on the Steering Committee since the NJR’s inception. Alex has been absolutely key in developing a professional research function, helping to guide and shape many influential pieces of work and supporting the inaugural NJR Fellowship scheme.”
In response to the appointment, Professor Mark Wilkinson added: “The NJR is the world’s largest repository of data on the outcomes of joint replacement and is a fantastic vehicle for answering questions about joint health that are important to patients. I am delighted to be joining the team at NJR, and would like to express my thanks to Alex and the Research Sub-committee for their welcome and support.”
Find out more about the work of the NJR Research Sub-committee and the new research application submission process here >
Professor Mark Wilkinson's biography
Professor Wilkinson received his medical degree in 1991 from Sheffield University, England. After completing a PhD in the metabolic and genetic aspects of joint replacement failure (2001) he undertook orthopaedic surgical training posts Sheffield and fellowship training in lower limb arthroplasty at Wrightington Hospital, and travelling fellowships Canada, Japan, and Switzerland. He was appointed to an academic Faculty post at Sheffield University in 2007, and to the Chair of Orthopaedics 2012.
Professor Wilkinson’s research focusses on the interaction between joint prostheses and the patient, and the genetic basis of joint disease. He conducted the first clinical trial of bisphosphonate therapy after hip replacement, and was the first to show genetic variability is a risk factor for prosthesis failure. More recently he was a PI in the arcOGEN study that identified several novel risk loci for osteoarthritis, and is currently conducting the first clinical trial of monoclonal antibody therapy to modulate osteolytic lesion activity.
Professor Wilkinson sits on the Research committees of the British Orthopaedic Association and Arthritis Research UK, and has sat as a board member of the Orthopaedic Research Society and as chair of its Awards and Recognition Committee. He is currently topic chair for Arthroplasty for its annual meeting, and a member of the Editorial Board of the Journal of Orthopaedic Research.
Professor Wilkinson is a recipient of the Robert Jones Gold Medal of the British Orthopaedic Association, The McKee Prize of the British Hip Society, and the William Harris Award of the Orthopaedic Research Society. He continues an active clinical practice in joint reconstruction and revision surgery with a particular interest in inflammatory arthritis, in addition to his ongoing clinical and translational research programme.